BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32759006)

  • 21. [Origin of SARS-CoV-2 theories, keys and unknowns of an emerged disease.].
    Estévez Reboredo RM
    Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32994390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC; Silverman RH
    Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
    [No Abstract]   [Full Text] [Related]  

  • 23. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
    Liu P; Jiang JZ; Wan XF; Hua Y; Li L; Zhou J; Wang X; Hou F; Chen J; Zou J; Chen J
    PLoS Pathog; 2020 May; 16(5):e1008421. PubMed ID: 32407364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 27. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactive memory T cells and herd immunity to SARS-CoV-2.
    Lipsitch M; Grad YH; Sette A; Crotty S
    Nat Rev Immunol; 2020 Nov; 20(11):709-713. PubMed ID: 33024281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.
    Dong R; Pei S; Yin C; He RL; Yau SS
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32526937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
    Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
    Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures.
    Mackenzie JS; Smith DW
    Asia Pac J Public Health; 2020 May; 32(4):145-153. PubMed ID: 32475144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the Evolutionary Origin of Mediterranean Sandfly Fever Viruses.
    Marklewitz M; Tchouassi DP; Hieke C; Heyde V; Torto B; Sang R; Junglen S
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A history of herd immunity.
    Jones D; Helmreich S
    Lancet; 2020 Sep; 396(10254):810-811. PubMed ID: 32950081
    [No Abstract]   [Full Text] [Related]  

  • 36. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
    Nelson CW; Ardern Z; Goldberg TL; Meng C; Kuo CH; Ludwig C; Kolokotronis SO; Wei X
    Elife; 2020 Oct; 9():. PubMed ID: 33001029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19).
    Olwenyi OA; Dyavar SR; Acharya A; Podany AT; Fletcher CV; Ng CL; Reid SP; Byrareddy SN
    J Mol Med (Berl); 2020 Oct; 98(10):1369-1383. PubMed ID: 32808094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
    Wong G; Bi YH; Wang QH; Chen XW; Zhang ZG; Yao YG
    Zool Res; 2020 May; 41(3):213-219. PubMed ID: 32314559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors preventing materno-fetal transmission of SARS-CoV-2.
    Celik O; Saglam A; Baysal B; Derwig IE; Celik N; Ak M; Aslan SN; Ulas M; Ersahin A; Tayyar AT; Duran B; Aydin S
    Placenta; 2020 Aug; 97():1-5. PubMed ID: 32501218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
    Barquera R; Collen E; Di D; Buhler S; Teixeira J; Llamas B; Nunes JM; Sanchez-Mazas A
    HLA; 2020 Sep; 96(3):277-298. PubMed ID: 32475052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.